How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code QTE: Thymidine Kinase Activity. View classification details, related manufacturers, 510(k) clearances, and recall records.
In vitro test to measure thymidine kinase activity (TKa) to aid in monitoring disease progression of breast cancer patients.Explore immunology records →
1 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jul 29, 2022 to Jul 29, 2022.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| QTE · Thymidine Kinase Activity | 1 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| DiviTum TKaK202852 · QTE | Biovica International AB | 510(k) | Jul 29, 2022FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.